FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489366316> ?p ?o ?g. }

• W1489366316 abstract "Background Wheeze is a common symptom in infancy and is a common cause for both primary care consultations and hospital admission. Beta2‐adrenoceptor agonists (b2‐agonists) are the most frequently used as bronchodilator but their efficacy is questionable. Objectives To determine the effectiveness of b2‐agonist for the treatment of infants with recurrent and persistent wheeze. Search methods We identified relevant trials using the Cochrane Airways Group Specialised register composed of records identified in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and PUBMED. We used the following terms to search the database: Wheeze or asthma and Infant or Child and Short acting beta‐agonist or Salbutamol (variants), Albuterol, Terbutaline (variants), Orciprenaline, Fenoterol. Selection criteria Randomised controlled trials comparing the effect of b2‐agonist against placebo in children under two years of age who had two or more previous episodes of wheeze, not related to another form of chronic lung disease. Data collection and analysis Eight studies met the criteria for inclusion in this meta‐analysis. The studies investigated patients in three settings: at home (three studies), in hospital (two studies) and in the pulmonary function laboratory (three studies). The main outcome measure was change in respiratory rate except for community based studies where symptom scores were used. Main results The studies were markedly heterogeneous and between study comparisons were limited. Improvement in respiratory rate, symptom score and oxygen saturation were noted in one study in the emergency department following two salbutamol nebulisers but this had no impact on hospital admission. There was a reduction in bronchial reactivity following salbutamol. There was no significant benefit from taking regular inhaled salbutamol on symptom scores recorded at home. Authors' conclusions There is no clear benefit of using b2‐agonists in the management of recurrent wheeze in the first two years of life although there is conflicting evidence. At present, further studies should only be performed if the patient group can be clearly defined and there is a suitable outcome parameter capable of measuring a response." @default.
• W1489366316 created "2016-06-24" @default.
• W1489366316 creator A5011442671 @default.
• W1489366316 creator A5040772092 @default.
• W1489366316 creator A5065343668 @default.
• W1489366316 creator A5084551736 @default.
• W1489366316 date "2002-04-22" @default.
• W1489366316 modified "2023-10-17" @default.
• W1489366316 title "Short acting beta2-agonists for recurrent wheeze in children under two years of age" @default.
• W1489366316 cites W1497467595 @default.
• W1489366316 cites W1967042520 @default.
• W1489366316 cites W1967616871 @default.
• W1489366316 cites W1981790554 @default.
• W1489366316 cites W1986215651 @default.
• W1489366316 cites W1988295200 @default.
• W1489366316 cites W1993750427 @default.
• W1489366316 cites W2005116916 @default.
• W1489366316 cites W2015380790 @default.
• W1489366316 cites W2021770633 @default.
• W1489366316 cites W2023577554 @default.
• W1489366316 cites W2027760323 @default.
• W1489366316 cites W2028163296 @default.
• W1489366316 cites W2033432842 @default.
• W1489366316 cites W2035912246 @default.
• W1489366316 cites W2043050097 @default.
• W1489366316 cites W2044936701 @default.
• W1489366316 cites W2045698960 @default.
• W1489366316 cites W2046586810 @default.
• W1489366316 cites W2050530156 @default.
• W1489366316 cites W2051777217 @default.
• W1489366316 cites W2052828518 @default.
• W1489366316 cites W2056783999 @default.
• W1489366316 cites W2065616406 @default.
• W1489366316 cites W2068085670 @default.
• W1489366316 cites W2069142372 @default.
• W1489366316 cites W2069340259 @default.
• W1489366316 cites W2074256742 @default.
• W1489366316 cites W2078980572 @default.
• W1489366316 cites W2092861518 @default.
• W1489366316 cites W2122586462 @default.
• W1489366316 cites W2134443733 @default.
• W1489366316 cites W2139183922 @default.
• W1489366316 cites W2143172275 @default.
• W1489366316 cites W2148765744 @default.
• W1489366316 cites W2154979015 @default.
• W1489366316 cites W2163349465 @default.
• W1489366316 cites W2169680608 @default.
• W1489366316 cites W2312397711 @default.
• W1489366316 doi "https://doi.org/10.1002/14651858.cd002873" @default.
• W1489366316 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8456461" @default.
• W1489366316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12137663" @default.
• W1489366316 hasPublicationYear "2002" @default.
• W1489366316 type Work @default.
• W1489366316 sameAs 1489366316 @default.
• W1489366316 citedByCount "46" @default.
• W1489366316 countsByYear W14893663162012 @default.
• W1489366316 countsByYear W14893663162014 @default.
• W1489366316 countsByYear W14893663162015 @default.
• W1489366316 countsByYear W14893663162016 @default.
• W1489366316 countsByYear W14893663162017 @default.
• W1489366316 countsByYear W14893663162018 @default.
• W1489366316 countsByYear W14893663162020 @default.
• W1489366316 countsByYear W14893663162021 @default.
• W1489366316 countsByYear W14893663162023 @default.
• W1489366316 crossrefType "journal-article" @default.
• W1489366316 hasAuthorship W1489366316A5011442671 @default.
• W1489366316 hasAuthorship W1489366316A5040772092 @default.
• W1489366316 hasAuthorship W1489366316A5065343668 @default.
• W1489366316 hasAuthorship W1489366316A5084551736 @default.
• W1489366316 hasBestOaLocation W14893663162 @default.
• W1489366316 hasConcept C126322002 @default.
• W1489366316 hasConcept C142724271 @default.
• W1489366316 hasConcept C177713679 @default.
• W1489366316 hasConcept C187212893 @default.
• W1489366316 hasConcept C204787440 @default.
• W1489366316 hasConcept C27081682 @default.
• W1489366316 hasConcept C2776042228 @default.
• W1489366316 hasConcept C2777394947 @default.
• W1489366316 hasConcept C2778338976 @default.
• W1489366316 hasConcept C2780252434 @default.
• W1489366316 hasConcept C2781018748 @default.
• W1489366316 hasConcept C71924100 @default.
• W1489366316 hasConceptScore W1489366316C126322002 @default.
• W1489366316 hasConceptScore W1489366316C142724271 @default.
• W1489366316 hasConceptScore W1489366316C177713679 @default.
• W1489366316 hasConceptScore W1489366316C187212893 @default.
• W1489366316 hasConceptScore W1489366316C204787440 @default.
• W1489366316 hasConceptScore W1489366316C27081682 @default.
• W1489366316 hasConceptScore W1489366316C2776042228 @default.
• W1489366316 hasConceptScore W1489366316C2777394947 @default.
• W1489366316 hasConceptScore W1489366316C2778338976 @default.
• W1489366316 hasConceptScore W1489366316C2780252434 @default.
• W1489366316 hasConceptScore W1489366316C2781018748 @default.
• W1489366316 hasConceptScore W1489366316C71924100 @default.
• W1489366316 hasIssue "1" @default.
• W1489366316 hasLocation W14893663161 @default.
• W1489366316 hasLocation W14893663162 @default.
• W1489366316 hasLocation W14893663163 @default.
• W1489366316 hasOpenAccess W1489366316 @default.
• W1489366316 hasPrimaryLocation W14893663161 @default.

• next